Company news

Vyome Holdings, Inc. news in 2025

Vyome Holdings, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company

December 22, 2025

Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval

December 7, 2025

Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program

November 24, 2025

Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing

November 17, 2025

Vyome Holdings Announces Results of Annual Shareholder Meeting

November 3, 2025

Vyome Holdings Acquires MIT AI Spinout Oculo Health

September 28, 2025

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity

September 17, 2025

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies

September 8, 2025

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity

September 3, 2025

Vyome Signs MoU with Embryyo, India’s Leading Medical Device Innovation Studio

August 20, 2025

Vyome Announces Strategic Review of Livechain (OTCID: LICH)

August 17, 2025

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell

August 15, 2025

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

August 13, 2025

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND

August 12, 2025

Vyome Announces New Board of Directors with Deep MIT and AI Ties

August 11, 2025

Decks in 2025